Market Closed -
Hong Kong S.E.
04:08:08 2024-06-27 am EDT
|
5-day change
|
1st Jan Change
|
0.034
HKD
|
0.00%
|
|
-5.56%
|
-39.29%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,441
|
1,040
|
983.6
|
379.6
|
522.1
|
239.3
|
Enterprise Value (EV)
1 |
2,638
|
1,351
|
1,121
|
497.9
|
608.4
|
392.6
|
P/E ratio
|
-17.4
x
|
-239
x
|
-6.51
x
|
-2.98
x
|
-11
x
|
5.83
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
9.23
x
|
2.64
x
|
3.09
x
|
1.7
x
|
3.2
x
|
1.11
x
|
EV / Revenue
|
9.98
x
|
3.43
x
|
3.52
x
|
2.23
x
|
3.73
x
|
1.82
x
|
EV / EBITDA
|
-54.6
x
|
-28.2
x
|
-130
x
|
54.7
x
|
163
x
|
10.5
x
|
EV / FCF
|
33.8
x
|
-134
x
|
-11.9
x
|
10
x
|
19.9
x
|
-33
x
|
FCF Yield
|
2.96%
|
-0.75%
|
-8.41%
|
9.98%
|
5.03%
|
-3.03%
|
Price to Book
|
21.3
x
|
6.42
x
|
6.89
x
|
18
x
|
4.97
x
|
1.64
x
|
Nbr of stocks (in thousands)
|
2,123,002
|
2,123,002
|
2,554,911
|
2,564,911
|
3,107,893
|
3,107,893
|
Reference price
2 |
1.150
|
0.4900
|
0.3850
|
0.1480
|
0.1680
|
0.0770
|
Announcement Date
|
7/25/18
|
7/17/19
|
7/16/20
|
7/22/21
|
7/22/22
|
7/20/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
264.5
|
393.5
|
318.1
|
223.1
|
163
|
216.1
|
EBITDA
1 |
-48.35
|
-47.91
|
-8.601
|
9.096
|
3.738
|
37.23
|
EBIT
1 |
-61.4
|
-63.9
|
-21.85
|
-0.057
|
-1.702
|
33.17
|
Operating Margin
|
-23.22%
|
-16.24%
|
-6.87%
|
-0.03%
|
-1.04%
|
15.35%
|
Earnings before Tax (EBT)
1 |
-142.1
|
-0.493
|
-55.48
|
-116.3
|
-41.64
|
43.77
|
Net income
1 |
-139.2
|
-4.344
|
-139.7
|
-127.4
|
-43.89
|
41.04
|
Net margin
|
-52.64%
|
-1.1%
|
-43.91%
|
-57.08%
|
-26.93%
|
18.99%
|
EPS
2 |
-0.0660
|
-0.002046
|
-0.0591
|
-0.0497
|
-0.0153
|
0.0132
|
Free Cash Flow
1 |
78.1
|
-10.09
|
-94.31
|
49.69
|
30.62
|
-11.89
|
FCF margin
|
29.53%
|
-2.56%
|
-29.64%
|
22.27%
|
18.78%
|
-5.5%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
546.28%
|
819.05%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/25/18
|
7/17/19
|
7/16/20
|
7/22/21
|
7/22/22
|
7/20/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
197
|
311
|
138
|
118
|
86.3
|
153
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-4.075
x
|
-6.487
x
|
-16.01
x
|
13.01
x
|
23.09
x
|
4.118
x
|
Free Cash Flow
1 |
78.1
|
-10.1
|
-94.3
|
49.7
|
30.6
|
-11.9
|
ROE (net income / shareholders' equity)
|
-76.1%
|
-5.72%
|
-33.5%
|
-163%
|
-72.9%
|
33.5%
|
ROA (Net income/ Total Assets)
|
-7.41%
|
-5.11%
|
-2.22%
|
-0.01%
|
-0.47%
|
7.07%
|
Assets
1 |
1,879
|
84.96
|
6,297
|
1,157,973
|
9,390
|
580.2
|
Book Value Per Share
2 |
0.0500
|
0.0800
|
0.0600
|
0.0100
|
0.0300
|
0.0500
|
Cash Flow per Share
2 |
0.0700
|
0.0300
|
0.0200
|
0.0100
|
0.0100
|
0
|
Capex
1 |
5.45
|
6.03
|
3.21
|
0.12
|
0.01
|
1.9
|
Capex / Sales
|
2.06%
|
1.53%
|
1.01%
|
0.05%
|
0%
|
0.88%
|
Announcement Date
|
7/25/18
|
7/17/19
|
7/16/20
|
7/22/21
|
7/22/22
|
7/20/23
|
|
1st Jan change
|
Capi.
|
---|
| -39.29% | 13.53M | | +12.97% | 8.27B | | +3.37% | 7.47B | | -15.13% | 5.23B | | -10.30% | 3.62B | | -19.61% | 3.26B | | -12.98% | 1.22B | | -31.16% | 1.06B | | -9.96% | 861M | | -4.54% | 858M |
Special Foods & Wellbeing Products
|